Results 11 to 20 of about 1,957,875 (298)

Korea hypertension fact sheet 2018 [PDF]

Clinical Hypertension, 2018
Background The Korea Hypertension Fact Sheet 2018 aims to overview the magnitude and management status of hypertension, and their trends in Korea. Methods The Hypertension Epidemiology Research Group analyzed the 1998–2016 Korea National Health and ...
The Korean Society Hypertension (KSH), Hypertension Epidemiology Research Working Group, Hyeon Chang Kim, Myeong-Chan Cho   +3 more
doaj   +3 more sources

Hypertension [PDF]

Annals of Internal Medicine, 2019
Essential hypertension is the chronic elevation in blood pressure of unknown origin, which is prevalent in 15-25% of the adult population and estimated to cause 4.5% of current global disease burden.
Mark Hamer (1254141)
core   +8 more sources

Hypertension [PDF]

American Journal of Kidney Diseases, 2004
Hypertension is a rapidly moving clinical field with frequent developments in new pharmacologic agents and management strategies. Perhaps more importantly, there have been substantial improvements in our understanding of how best to use the drugs ...
Farrugia, Emanuel
core   +3 more sources

Hypertension [PDF]

Pediatrics in Review, 2012
Hypertension is responsible for roughly one-in-six adult deaths annually in the United States and is associated with five of the top nine causes of death. 1 Ten trillion dollars is the estimated annual cost worldwide of the direct and indirect effects of hypertension. 2,3
Fitzgerald, Kara, LePine, Todd
  +8 more sources

Sodium‐Glucose Cotransporter 2 Inhibitor Canagliflozin Antagonizes Salt‐Sensitive Hypertension Through Modifying Transient Receptor Potential Channels 3 Mediated Vascular Calcium Handling

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Salt‐sensitive hypertension is highly prevalent and associated with cardiorenal damage. Large clinical trials have demonstrated that SGLT2 (sodium‐glucose cotransporter 2) inhibitors exert hypotensive effect and cardiorenal protective benefits
Yu Zhao, Li Li, Zongshi Lu, Yingru Hu, Hexuan Zhang, Fang Sun, Qiang Li, Chengkang He, Wentao Shu, Lijuan Wang, Tingbing Cao, Zhidan Luo, Zhencheng Yan, Daoyan Liu, Peng Gao, Zhiming Zhu   +15 more
doaj   +1 more source

Hypertension [PDF]

Current Treatment Options in Cardiovascular Medicine, 1991
Controlled multicenter clinical trials and almost 50 years of clinical experience have demonstrated incontrovertibly the efficacy, safety, and feasibility of antihypertensive pharmacotherapy. In addition, this vast clinical record has shown, through the intrinsic ability of antihypertensive therapy to control arterial pressure, how to prevent and ...
G W, Ching, D G, Beevers
openaire   +4 more sources

Poor sleep quality is negatively associated with low cognitive performance in general population independent of self-reported sleep disordered breathing

BMC Public Health, 2022
Background Sleep disordered breathing (SDB) plays a significant role in both sleep quality and cognition and whether it has an impact on the relationship between above two factors remains to be clear.
Zhongrong Wang, Mulalibieke Heizhati, Lin Wang, Mei Li, Zhikang Yang, Mengyue Lin, Reyila Abudereyimu, Jing Hong, Wenbo Yang, Ling Yao, Shasha Liu, Junli Hu, Nanfang Li   +12 more
doaj   +1 more source

Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease

Cardiovascular Diabetology, 2022
Background Altered adipokine secretion in dysfunctional adipose tissue facilitates the development of atherosclerotic diseases including lower extremity peripheral artery disease (PAD).
Mei You, Yushuang Liu, Bowen Wang, Li Li, Hexuan Zhang, Hongbo He, Qing Zhou, Tingbing Cao, Lijuan Wang, Zhigang Zhao, Zhiming Zhu, Peng Gao, Zhencheng Yan   +12 more
doaj   +1 more source

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension [PDF]

, 2011
Background: Endothelin-1 signalling plays an important role in pathogenesis of pulmonary hypertension. Although different endothelin-A receptor antagonists are developed, a novel therapeutic option to cure the disease is still needed.
Norbert Weissmann, Sydykov, Akylbek, Brandes, Ralf, Schermuly, Ralph T., Hossein A Ghofrani, Janssen, Wiebke, Seeger Werner, Ralf P Brandes, Neil Davie, Dahal, Bhola K., Davie, Neil, Janssen Wiebke, Davie Neil, Ghofrani Hossein A, Seeger, Werner, Cornitescu, Teodora, Brandes Ralf P, Cornitescu Teodora, Kosanovic, Djuro, Kojonazarov, Baktybek, Werner Seeger, Friedrich Grimminger, Ghofrani, Hossein Ardeschir, Grimminger, Friedrich, Dahal Bhola K, Djuro Kosanovic, Baktybek Kojonazarov, Teodora Cornitescu, Schermuly Ralph T, Sydykov Akylbek, Wiebke Janssen, Grimminger Friedrich, Akylbek Sydykov, Kojonazarov Baktybek, Weissmann Norbert, Himal Luitel, Luitel Himal, Ralph T Schermuly, Luitel, Himal, Weißmann, Norbert, Bhola K Dahal, Kosanovic Djuro   +41 more
core   +2 more sources

Clinical Characteristics of Target Organ Damage in Primary Aldosteronism with or without Metabolic Syndrome

Journal of Diabetes Research, 2022
The aim of this study is to investigate the prevalence of metabolic disorders in patients with primary aldosteronism (PA) and target organ damage (TOD) in different subtypes of patients with PA with or without metabolic syndrome (MS).
Xiaona Bu, Fang Sun, Hexuan Zhang, Xiaoli Liu, Zhigang Zhao, Hongbo He, Yingsha Li, Zhencheng Yan, Zhiming Zhu   +8 more
doaj   +1 more source